African Impey fails drugs test
Send a link to a friend
[July 02, 2014]
PARIS (Reuters) - South African
Daryl Impey, who wore the yellow jersey on last year's Tour de France,
failed an anti-doping test for the masking agent Probenecid, the
Orica-GreenEdge rider said on Wednesday.
Probenecid is used to mask the use of doping substances, anabolic
drugs in particular.
Impey was not included in Orica-GreenEdge's nine-man Tour de France
team, which came as a surprise when the Australian outfit made their
announcement on Tuesday.
"Further to the announcement of the Tour de France team and in the
interests of full disclosure, I confirm that on 23 June 2014, I was
notified by William Newman, the President of Cycling South Africa,
about an adverse analytical finding for Probenecid following an
in-competition test at the national time trial championships on 6
February 2014," Impey said in a statement.
"I had no knowledge of Probenecid nor have I ever taken the
substance knowingly in any manner. I am committed to drug-free sport
and fully intend to take all steps necessary to clear myself of any
"The notification came as a complete shock to me just days before
the start of the Tour de France, particularly since anti-doping
tests conducted on me on 8 and 9 February 2014 yielded no adverse
"I immediately flew back to South Africa and was present at the
analysis of my B sample on 27 June 2014, the results of which
confirmed the initial analysis."
[to top of second column]
The Tour de France starts in Leeds, England on Saturday.
Last year, all-rounder Impey became the first African rider to wear
the yellow jersey on the Tour de France when he led the overall
standings during stages 6 and 7.
(Reporting by Julien Pretot; Editing by John O'Brien)
[© 2014 Thomson Reuters. All rights
Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.